Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.

Kim Y, Kim E, Wu Q, Guryanova O, Hitomi M, Lathia JD, Serwanski D, Sloan AE, Weil RJ, Lee J, Nishiyama A, Bao S, Hjelmeland AB, Rich JN.

Genes Dev. 2012 Jun 1;26(11):1247-62. doi: 10.1101/gad.193565.112.

2.

Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments.

Ehnman M, Missiaglia E, Folestad E, Selfe J, Strell C, Thway K, Brodin B, Pietras K, Shipley J, Östman A, Eriksson U.

Cancer Res. 2013 Apr 1;73(7):2139-49. doi: 10.1158/0008-5472.CAN-12-1646. Epub 2013 Jan 21.

3.

Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells.

Ball SG, Bayley C, Shuttleworth CA, Kielty CM.

Biochem J. 2010 Mar 15;427(1):29-40. doi: 10.1042/BJ20091512.

4.

Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3.

Guryanova OA, Wu Q, Cheng L, Lathia JD, Huang Z, Yang J, MacSwords J, Eyler CE, McLendon RE, Heddleston JM, Shou W, Hambardzumyan D, Lee J, Hjelmeland AB, Sloan AE, Bredel M, Stark GR, Rich JN, Bao S.

Cancer Cell. 2011 Apr 12;19(4):498-511. doi: 10.1016/j.ccr.2011.03.004.

5.

Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.

Garner JM, Ellison DW, Finkelstein D, Ganguly D, Du Z, Sims M, Yang CH, Interiano RB, Davidoff AM, Pfeffer LM.

PLoS One. 2015 May 8;10(5):e0125838. doi: 10.1371/journal.pone.0125838. eCollection 2015 May 8. Erratum in: PLoS One. 2015;10(12):e0145052.

6.

REST regulates oncogenic properties of glioblastoma stem cells.

Kamal MM, Sathyan P, Singh SK, Zinn PO, Marisetty AL, Liang S, Gumin J, El-Mesallamy HO, Suki D, Colman H, Fuller GN, Lang FF, Majumder S.

Stem Cells. 2012 Mar;30(3):405-14. doi: 10.1002/stem.1020. Erratum in: Stem Cells. 2012 May;30(5):1049.

7.

FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.

Gong AH, Wei P, Zhang S, Yao J, Yuan Y, Zhou AD, Lang FF, Heimberger AB, Rao G, Huang S.

Cancer Res. 2015 Jun 1;75(11):2337-48. doi: 10.1158/0008-5472.CAN-14-2800. Epub 2015 Apr 1.

8.

PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.

Meng F, Speyer CL, Zhang B, Zhao Y, Chen W, Gorski DH, Miller FR, Wu G.

Cancer Res. 2015 Feb 1;75(3):584-93. doi: 10.1158/0008-5472.CAN-13-3029. Epub 2014 Dec 10.

9.

Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.

Dobbin E, Graham C, Corrigan PM, Thomas KG, Freeburn RW, Wheadon H.

Exp Hematol. 2009 Jan;37(1):111-121. doi: 10.1016/j.exphem.2008.09.012.

PMID:
19100521
10.

RasGAP Promotes Autophagy and Thereby Suppresses Platelet-Derived Growth Factor Receptor-Mediated Signaling Events, Cellular Responses, and Pathology.

Lei H, Qian CX, Lei J, Haddock LJ, Mukai S, Kazlauskas A.

Mol Cell Biol. 2015 May;35(10):1673-85. doi: 10.1128/MCB.01248-14. Epub 2015 Mar 2.

11.

Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer.

Reinmuth N, Liersch R, Raedel M, Fehrmann F, Fehrmann N, Bayer M, Schwoeppe C, Kessler T, Berdel W, Thomas M, Mesters RM.

Int J Cancer. 2009 Apr 1;124(7):1535-44. doi: 10.1002/ijc.24109.

12.

PDGF receptor beta is a potent regulator of mesenchymal stromal cell function.

Tokunaga A, Oya T, Ishii Y, Motomura H, Nakamura C, Ishizawa S, Fujimori T, Nabeshima Y, Umezawa A, Kanamori M, Kimura T, Sasahara M.

J Bone Miner Res. 2008 Sep;23(9):1519-28. doi: 10.1359/jbmr.080409.

13.

Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma.

Singer E, Judkins J, Salomonis N, Matlaf L, Soteropoulos P, McAllister S, Soroceanu L.

Cell Death Dis. 2015 Jan 15;6:e1601. doi: 10.1038/cddis.2014.566.

14.

Platelet-derived growth factor receptors form complexes with neuropilin-1 during megakaryocytic differentiation of thrombopoietin-dependent UT-7/TPO cells.

Ohsaka A, Hirota-Komatsu S, Araki M, Komatsu N.

Biochem Biophys Res Commun. 2015 Apr 10;459(3):443-9. doi: 10.1016/j.bbrc.2015.02.124. Epub 2015 Mar 2.

PMID:
25744030
15.

Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.

Zhou J, Yi L, Ouyang Q, Xu L, Cui H, Xu M.

Cell Signal. 2014 Dec;26(12):2896-902. doi: 10.1016/j.cellsig.2014.08.027. Epub 2014 Sep 6.

PMID:
25200966
16.

Inhibition of prostate cancer using RNA interference-directed knockdown of platelet-derived growth factor receptor.

Park YH, Seo SY, Ha M, Ku JH, Kim HH, Kwak C.

Urology. 2011 Jun;77(6):1509.e9-15. doi: 10.1016/j.urology.2011.01.050. Epub 2011 Apr 11.

PMID:
21481440
17.
18.

Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.

Szerlip NJ, Pedraza A, Chakravarty D, Azim M, McGuire J, Fang Y, Ozawa T, Holland EC, Huse JT, Jhanwar S, Leversha MA, Mikkelsen T, Brennan CW.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3041-6. doi: 10.1073/pnas.1114033109. Epub 2012 Feb 8.

19.

Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.

Gatti M, Pattarozzi A, Bajetto A, Würth R, Daga A, Fiaschi P, Zona G, Florio T, Barbieri F.

Toxicology. 2013 Dec 15;314(2-3):209-20. doi: 10.1016/j.tox.2013.10.003. Epub 2013 Oct 21.

PMID:
24157575
20.

PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.

Cenciarelli C, Marei HE, Zonfrillo M, Pierimarchi P, Paldino E, Casalbore P, Felsani A, Vescovi AL, Maira G, Mangiola A.

Mol Cancer. 2014 Nov 8;13:247. doi: 10.1186/1476-4598-13-247.

Supplemental Content

Support Center